Yu Yong
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Yu Yong. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| GNLX | SVP, Clinical Development | Award / Grant | 101,480 | — | — | Aug 27, 2025 |
| GNLX | SVP, Clinical Development | Sale | 973 | $5.37 | $5,225 | Aug 21, 2025 |
| GNLX | VP, Clinical Trial Operations | Sale | 5,579 | $2.92 | $16,291 | May 12, 2025 |
| GNLX | VP, Clinical Trial Operations | Award / Grant | 13,350 | — | — | Mar 14, 2025 |
| GNLX | VP, Clinical Trial Operations | Award / Grant | 29,000 | — | — | Dec 18, 2024 |
| GNLX | VP, Clinical Trial Operations | Award / Grant | 11,557 | — | — | Jun 24, 2024 |
| GNLX | VP, Clinical Trial Operations | Purchase | 2,500 | — | — | May 29, 2024 |
| GNLX | VP, Clinical Trial Operations | Sale | 26,732 | $12.94 | $345,912 | Dec 15, 2023 |
| GNLX | VP, Clinical Trial Operations | Sale | 36,800 | $11.85 | $436,080 | Dec 7, 2023 |
| GNLX | VP, Clinical Trial Operations | Sale | 18,665 | $10.26 | $191,503 | Nov 21, 2023 |
| GNLX | VP, Clinical Trial Operations | Sale | 3,541 | $13.04 | $46,175 | Nov 20, 2023 |
| GNLX | VP, Clinical Trial Operations | Option Exercise | 5,200 | $6.00 | $31,200 | Oct 24, 2023 |
| GNLX | VP, Clinical Trial Operations | Sale | 4,800 | $21.94 | $105,312 | Oct 10, 2023 |
| GNLX | VP, Clinical Trial Operations | Option Exercise | 5,200 | $6.00 | $31,200 | Sep 26, 2023 |
| GNLX | VP, Clinical Trial Operations | Sale | 6,000 | $27.96 | $167,760 | Sep 20, 2023 |
| GNLX | VP, Clinical Trial Operations | Sale | 5,725 | $21.56 | $123,431 | Sep 15, 2023 |
| GNLX | VP, Clinical Trial Operations | Sale | 29,800 | $21.14 | $629,972 | Sep 13, 2023 |
| GNLX | VP, Clinical Trial Operations | Sale | 19,800 | $24.70 | $489,060 | Aug 30, 2023 |
| GNLX | VP, Clinical Trial Operations | Sale | 3,265 | $23.73 | $77,478 | Aug 18, 2023 |